Free Trial

Kodiak Sciences (KOD) Competitors

Kodiak Sciences logo
$10.20 +0.49 (+5.05%)
Closing price 04:00 PM Eastern
Extended Trading
$9.89 -0.31 (-3.04%)
As of 05:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KOD vs. OCUL, AGIO, DNLI, GLPG, IDYA, SRPT, BLTE, HRMY, IRON, and MESO

Should you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Ocular Therapeutix (OCUL), Agios Pharmaceuticals (AGIO), Denali Therapeutics (DNLI), Galapagos (GLPG), IDEAYA Biosciences (IDYA), Sarepta Therapeutics (SRPT), Belite Bio (BLTE), Harmony Biosciences (HRMY), Disc Medicine (IRON), and Mesoblast (MESO). These companies are all part of the "pharmaceutical products" industry.

Kodiak Sciences vs. Its Competitors

Kodiak Sciences (NASDAQ:KOD) and Ocular Therapeutix (NASDAQ:OCUL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Kodiak Sciences presently has a consensus price target of $11.75, suggesting a potential upside of 15.20%. Ocular Therapeutix has a consensus price target of $17.20, suggesting a potential upside of 39.84%. Given Ocular Therapeutix's stronger consensus rating and higher probable upside, analysts clearly believe Ocular Therapeutix is more favorable than Kodiak Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kodiak Sciences
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Ocular Therapeutix
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Kodiak Sciences has a net margin of 0.00% compared to Ocular Therapeutix's net margin of -382.51%. Ocular Therapeutix's return on equity of -71.92% beat Kodiak Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Kodiak SciencesN/A -155.27% -63.29%
Ocular Therapeutix -382.51%-71.92%-49.36%

In the previous week, Kodiak Sciences had 21 more articles in the media than Ocular Therapeutix. MarketBeat recorded 22 mentions for Kodiak Sciences and 1 mentions for Ocular Therapeutix. Ocular Therapeutix's average media sentiment score of 1.10 beat Kodiak Sciences' score of 0.40 indicating that Ocular Therapeutix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kodiak Sciences
4 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Ocular Therapeutix
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kodiak Sciences has higher earnings, but lower revenue than Ocular Therapeutix. Ocular Therapeutix is trading at a lower price-to-earnings ratio than Kodiak Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kodiak SciencesN/AN/A-$176.21M-$3.80-2.68
Ocular Therapeutix$56.66M37.77-$193.51M-$1.28-9.61

89.1% of Kodiak Sciences shares are held by institutional investors. Comparatively, 59.2% of Ocular Therapeutix shares are held by institutional investors. 45.9% of Kodiak Sciences shares are held by insiders. Comparatively, 2.3% of Ocular Therapeutix shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Kodiak Sciences has a beta of 2.41, indicating that its share price is 141% more volatile than the S&P 500. Comparatively, Ocular Therapeutix has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500.

Summary

Ocular Therapeutix beats Kodiak Sciences on 8 of the 15 factors compared between the two stocks.

Get Kodiak Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KOD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOD vs. The Competition

MetricKodiak SciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$538.76M$3.09B$5.82B$9.74B
Dividend YieldN/A2.23%3.84%4.09%
P/E Ratio-2.6821.1431.1525.97
Price / SalesN/A399.83475.57123.18
Price / CashN/A43.0937.1558.38
Price / Book7.678.079.116.39
Net Income-$176.21M-$54.72M$3.26B$265.66M
7 Day Performance-3.50%2.62%2.11%1.98%
1 Month Performance82.80%7.63%5.12%1.33%
1 Year Performance280.60%13.11%31.25%21.15%

Kodiak Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOD
Kodiak Sciences
3.2361 of 5 stars
$10.20
+5.0%
$11.75
+15.2%
+248.0%$538.76MN/A-2.6890Analyst Revision
OCUL
Ocular Therapeutix
3.9674 of 5 stars
$12.31
-2.5%
$17.20
+39.7%
+31.4%$2.20B$63.72M-9.62230
AGIO
Agios Pharmaceuticals
4.3577 of 5 stars
$37.45
+1.2%
$56.33
+50.4%
-18.9%$2.15B$36.50M3.40390
DNLI
Denali Therapeutics
4.204 of 5 stars
$14.82
+0.8%
$33.62
+126.8%
-39.1%$2.15B$330.53M-5.29430News Coverage
GLPG
Galapagos
0.133 of 5 stars
$32.91
+1.4%
$25.33
-23.0%
+26.6%$2.14B$275.61M0.001,310
IDYA
IDEAYA Biosciences
4.5409 of 5 stars
$24.75
+1.7%
$48.09
+94.3%
-38.0%$2.13B$7M-6.5380
SRPT
Sarepta Therapeutics
4.6432 of 5 stars
$20.99
-3.8%
$43.63
+107.8%
-86.0%$2.13B$1.90B-24.131,372Trending News
Analyst Forecast
Short Interest ↑
BLTE
Belite Bio
2.6287 of 5 stars
$64.95
-2.5%
$96.67
+48.8%
+32.5%$2.12BN/A-41.9010
HRMY
Harmony Biosciences
4.5893 of 5 stars
$36.41
-1.2%
$51.00
+40.1%
+1.3%$2.12B$714.73M11.75200Positive News
IRON
Disc Medicine
3.5433 of 5 stars
$58.84
-1.7%
$96.18
+63.5%
+21.2%$2.08BN/A-13.1630
MESO
Mesoblast
2.3228 of 5 stars
$15.93
-2.0%
$18.00
+13.0%
+133.0%$2.08B$5.90M0.0080News Coverage
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:KOD) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners